Alnylam director granted 4,393 stock options
ALNYLAM PHARMACEUTICALS, INC. director Benjamin Cravatt reported a compensation-related stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ALNYLAM PHARMACEUTICALS, INC. director Benjamin Cravatt reported a compensation-related stock option grant. He received options to buy 4,393 shares of common stock at an exercise price of $295.63 per share. The options vest in three equal annual installments starting on the first anniversary of the grant date and expire in 2036. Following this grant, he holds 4,393 derivative securities directly.
Insider Trade Summary
Grant/Award: 4,393 shares
Grant/Award
1 txn
Insider
Cravatt Benjamin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 4,393 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,393 contracts (Direct)
Footnotes (1)
- F1. The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.
Key Figures
Options granted: 4,393 options
Exercise price: $295.63 per share
Total derivative holdings: 4,393 options
+2 more
5 metrics
Options granted
4,393 options
Stock Option (Right to Buy) grant to director Benjamin Cravatt
Exercise price
$295.63 per share
Conversion or exercise price for the stock options
Total derivative holdings
4,393 options
Total derivative securities following the reported transaction
Vesting schedule
1/3 annually over 3 years
One third vests on each of the first three anniversaries of grant
Option expiration date
June 1, 2036
Expiration date of the stock option grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 295.6300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option will vest as to one third of the shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-01T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ALNY (ALNY) director Benjamin Cravatt report in this Form 4 filing?
Benjamin Cravatt reported receiving a stock option grant for 4,393 shares of ALNY common stock. The options are compensation-related, not an open-market trade, and give him the right to buy shares at a fixed exercise price in the future.
How many Alnylam Pharmaceuticals (ALNY) stock options were granted to Benjamin Cravatt?
Benjamin Cravatt was granted stock options covering 4,393 shares of Alnylam common stock. These derivative securities give him the right to purchase that number of shares, subject to vesting and other terms described in the filing’s footnote.
What is the exercise price of Benjamin Cravatt’s ALNY stock options?
The granted options have an exercise price of $295.63 per share. This means Cravatt can purchase Alnylam common stock at $295.63 for each option, once vested and before the options expire, regardless of the market price at that time.
When do Benjamin Cravatt’s Alnylam stock options vest according to the Form 4?
The stock options vest in three equal installments on the first, second, and third anniversaries of the grant date. Each year, approximately one third of the 4,393 options becomes exercisable, aligning the award with multi-year service at Alnylam.
What is the expiration date of the ALNY stock options granted to Benjamin Cravatt?
The stock options granted to Benjamin Cravatt expire on June 1, 2036. After that expiration date, any unexercised options become worthless, so they must be exercised, if at all, between vesting and that 2036 expiration.
How many derivative securities does Benjamin Cravatt hold after this ALNY option grant?
Following the reported transaction, Benjamin Cravatt beneficially owns 4,393 derivative securities related to Alnylam common stock. This figure matches the size of the new option grant, reflecting his position as reported in this specific Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates